Prem Premsrirut is the CEO and Founder of Mirimus, a biotechnology company specializing in the design, development and deployment of RNAi technologies to model and understand disease. Under her leadership, the company has developed technologies that have greatly improved the efficiency and cost-effectiveness of RNAi-based drug discovery and development. Dr. Premsrirut holds a Ph.D. in Molecular and Cell Biology from Stony Brook University and completed her postdoctoral training at the Cold Spring Harbor Laboratory. Her vision and expertise have positioned Mirimus at the forefront of the biotechnology industry.More...